The doubling potential of T lymphocytes allows clinical-grade production of a bank of genetically modified monoclonal T-cell populations
Conclusion The possibility of choosing rare donors and exploiting the natural proliferative potential of T lymphocytes may dramatically reduce the clinical and immunologic complexity of adoptive transfer protocols that rely on the use of third-party T-cell populations.
Source: Cytotherapy - Category: Cytology Source Type: research
More News: Allergy & Immunology | Depression | Genetics | Leukemia | Men | Stem Cell Therapy | Stem Cells | Suicide | Transplants